Risk Evaluation and Mitigation Strategies (REMS) is a drug safety program that the FDA can require or certain medications that have serious safety concerns. For pharmacies, this introduces a new level of responsibility from a regulatory perspective. This session will explore the implications for both traditional and specialty pharmacies.